ExploreWatchlistsPricing
  1. JP-listed companies
  2. BML, INC.
  3. Financials
  4. Cash and cash equivalents

BML, INC. (4694)

Market cap
¥147.8B
P/E ratio
18.7x
BML provides clinical laboratory testing services to hospitals and clinics across Japan, along with food safety testing and clinical trial support through its network of specialized subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash and cash equivalents (Million JPY)YoY (%)
Mar 31, 202644,616-33.96%
Mar 31, 202567,562-8.84%
Mar 31, 202474,114-14.34%
Mar 31, 202386,521-6.08%
Mar 31, 202292,126+45.13%
Mar 31, 202163,478+23.95%
Mar 31, 202051,213-1.31%
Mar 31, 201951,892+12.01%
Mar 31, 201846,327+12.22%
Mar 31, 201741,281+11.46%
Mar 31, 201637,037+19.38%
Mar 31, 201531,024

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat